Caring Brands (CABR) Return on Sales (2024 - 2025)
Caring Brands (CABR) recorded quarterly Return on Sales of 88.95% in Q4 2025, down 546.13% quarter-over-quarter from 13.77% in Q3 2025, and down 7040.0% on a YoY basis from 1.28% in Q4 2024.
Caring Brands (CABR) Return on Sales (2024 - 2025) Analysis & Trends
Caring Brands' Return on Sales history runs 2 years deep, the most recent figure standing at 88.95% for Q4 2025.
- In Q4 2025, Return on Sales fell 7040.0% year-over-year to 88.95%; the TTM figure through Dec 2025 stood at 19.9% (changed N/A YoY), while the FY2025 annual figure was 14.13%, changed N/A from the prior year.
- Return on Sales was 88.95% for Q4 2025 at Caring Brands, down from 13.77% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 3.67% in Q1 2025 to a low of 88.95% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.00% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.00% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.00% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.00% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.00% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.02% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 0.00% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.00% |
| 10 | Caring Brands | 17.34 Mn | 19.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -88.95% |
| Sep 30, 2025 | -13.77% |
| Mar 31, 2025 | -3.67% |
| Dec 31, 2024 | -18.55% |